Last $7.26 USD
Change Today -0.38 / -4.97%
Volume 1.7M
ECYT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

P. Ron Ellis

Co-Founder, Chief Executive Officer, President and Director, Endocyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
52$2,458,065
As of Fiscal Year 2013

Background*

Mr. P. Ron Ellis is a Co-Founder of Endocyte, Inc. and has been its Chief Executive Officer and President since January 1996. Mr. Ellis joined Endocyte, Inc. in January 1996. Mr. Ellis has over 18 years of health care and biotechnology experience. He served as Vice President of Hill-Rom. While at Hill-Rom, he served in a variety of positions in marketing, product development, mergers/acquisitions, business development, corporate strategy and general management. Mr. Ellis ...

Read Full Background

Corporate Headquarters*

3000 Kent Avenue
West Lafayette, Indiana 47906

United States

Phone: 765-463-7175
Fax: 765-463-9271

Board Members Memberships*

1995-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

BS
Brigham Young University
MBA
Brigham Young University

Other Affiliations*

Annual Compensation*

Salary$452,649
Bonus$269,326
Total Annual Compensation$721,975

Stock Options*

All Other Compensation$840
Exercised Options18,000
Exercised Options Value$226,020
Exercisable Options581,255
Exercisable Options Value$4,031,105
Unexercisable Options453,023
Unexercisable Options Value$1,401,038
Total Value of Options$5,658,162
Total Number of Options1,052,278

Total Compensation*

Total Annual Cash Compensation$722,815
Total Short Term Compensation$721,975
Other Long Term Compensation$840
Total Calculated Compensation$2,458,065
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECYT:US $7.26 USD -0.38

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDOCYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.